{
    "clinical_study": {
        "@rank": "139610", 
        "arm_group": [
            {
                "arm_group_label": "METHOTREXATE", 
                "arm_group_type": "Active Comparator", 
                "description": "In step 1, 55 patients will receive methotrexate 10mg / m\u00b2 orally once a week, (at split doses of 5 mg/m2 in the morning and 5 mg/m2 at night), that is to say 2 tablets of 2.5 mg at each take\nIn step 2, responders at Month 4 (CR or PR) will be treated during 8 additional months with methotrexate at the same dosage.\nNon responders at Month 4 will be randomized and treated either by:\nCyclophosphamide delivered at 100 mg orally once daily, that is to say 2 tablets of 50 mg at each take between Month 5 and Month 8, decreased to 50 mg orally once daily beyond Month 8 for responders at Month 8;\nCiclosporine A delivered at 3 mg/kg per day (at split doses of 1.5 mg/kg in the morning and 1.5 mg/kg at night) orally administered."
            }, 
            {
                "arm_group_label": "CYCLOPHOSPHAMIDE", 
                "arm_group_type": "Active Comparator", 
                "description": "In step 1, 55 patients will receive cyclophosphamide 100 mg orally once daily, that is to say 2 tablets of 50 mg at each take.\nIn step 2, responders at Month 4 (CR or PR) will be treated during 8 additional months  with cyclophosphamide (at 50 mg orally once daily);\nNon responders at Month 4 will be randomized and treated either by:\nMethotrexate administered at 10 mg/m2 orally once a week (at split doses of 5 mg/m2 in the morning and 5 mg/m2 at night), that is to say 2 tablets of 2.5 mg at each take;\nCiclosporine A delivered at 3 mg/kg per day (at split doses of 1.5 mg/kg in the morning and 1.5 mg/kg at night) orally administered."
            }
        ], 
        "brief_summary": {
            "textblock": "LGL leukemia represents a rare subtype of chronic T or NK lymphoproliferative disorders. It\n      is an indolent disease, the main hematological or autoimmune complications lead to a\n      treatment in more than 60% of patients.\n\n      Investigators set up at the University Hospital of Rennes, a database of more than 300\n      patients with LGL leukemia from major French services that support this disease, and\n      published  in 2010 the largest series of patients in the world (n = 229). However, the\n      limited heterogeneity and retrospective data collected, as all previously released, makes it\n      difficult  the proposal of consensual treatment options. If first and second line treatments\n      are based on the use of immunosuppression with methotrexate, cyclophosphamide, or\n      cyclosporin A, no molecule has proven superiority over others. Methotrexate and\n      cyclophosphamide are mainly used in the first line. Invetigators just have in the literature\n      data on about 100 patients treated with either of these drugs. Combining the results of our\n      series with those in the literature, invetigators estimate the respective overall response\n      rate (RG) and complete response rate (CR) in 55% and 30% for methotrexate, and 60% and 50%\n      for cyclophosphamide.\n\n      Thus, there are four objective in this study :\n\n        1. to compare the respective efficacies of methotrexate and cyclophosphamide when\n           administered as first-line therapies in patients suffering from T/NK LGL leukemia with\n           severe neutropenia or neutropenia associated with infections, and/or anemia requiring\n           transfusions, and/or auto-immune associated disease\n\n        2. to evaluate the percentage of patients refractory to methotrexate or cyclophosphamide\n           for which a second line treatment is efficacious\n\n        3. to explore, in case of non-response to the first-line therapy, the efficacy of\n           ciclosporine A, the comparison being performed with the treatment which was not\n           administered in the first-line therapy\n\n        4. to evaluate the response rate according to the phenotypic subtype of LGL leukemia."
        }, 
        "brief_title": "Prospective, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia", 
        "completion_date": {
            "#text": "March 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Large Granular Lymphocytes Leukemia", 
        "condition_browse": {
            "mesh_term": [
                "Leukemia", 
                "Leukemia, Large Granular Lymphocytic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Large Granular Lymphocyte (LGL) leukemia is a clonal disorder involving tissue invasion of\n      marrow, spleen and liver. Clinical presentation is dominated by recurrent infections\n      associated with neutropenia, anemia, splenomegaly, and auto-immune diseases, particularly\n      rheumatoid arthritis. Both T cell and NK cell subtypes of LGL leukemia are indolent disease\n      and considered as a chronic illness and lead to a treatment in more than 60% of patients.\n\n      LGL leukemia displays a chronic clinical course. Recommendations regarding therapy are\n      similar for both subtypes. Indications for treatment include 1) severe neutropenia (ANC <500\n      mm3); 2) neutropenia (ANC <1500mm3) with symptomatic recurrent infections; 3) symptomatic or\n      transfusion-dependent anemia and 4) associated autoimmune conditions requiring therapy, most\n      often rheumatoid arthritis.\n\n      There is no standard treatment for patients with LGL leukemia. The numerous case reports\n      published do not provide a consensus for a particular treatment. All the six largest series\n      published in the literature so far (collecting data on more than 40 patients) are\n      retrospective.\n\n      Immunosuppressive therapy remains the foundation of treatment including single three agents\n      i.e. methotrexate, oral cyclophosphamide and ciclosporin A. However prospective trials\n      involving large numbers of patients have not been performed and no molecule has proven\n      superiority over others.\n\n      Invetigators set up at the University Hospital of Rennes, a database of more than 300\n      patients with LGL leukemia from major French services that support this disease, and\n      published  in 2010 the largest series of patients in the world (n = 229). However, the\n      limited heterogeneity and retrospective data collected, as all previously released, makes it\n      difficult  the proposal of consensual treatment options. Combining the results of our series\n      with those of the literature, invetigators estimate that overall response rate and complete\n      response rate are 55% and 30% with methotrexate, 60% and 50% with cyclophosphamide, and 55%\n      and less than 20% with ciclosporine A, respectively.\n\n      Thus, there are four objective in this study :\n\n        1. to compare the respective efficacies of methotrexate and cyclophosphamide when\n           administered as first-line therapies in patients suffering from T/NK LGL leukemia with\n           severe neutropenia or neutropenia associated with infections, and/or anemia requiring\n           transfusions, and/or auto-immune associated disease\n\n        2. to evaluate the percentage of patients refractory to methotrexate or cyclophosphamide\n           for which a second line treatment is efficacious\n\n        3. to explore, in case of non-response to the first-line therapy, the efficacy of\n           ciclosporine A, the comparison being performed with the treatment which was not\n           administered in the first-line therapy\n\n        4. to evaluate the response rate according to the phenotypic subtype of LGL leukemia."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Common criteria of LGL leukemia: the diagnosis is based on a chronic LGL peripheral\n             blood expansion (>0.5x109/L), usually lasting more than 6 months\n\n          -  Specific criteria for T-LGL leukemia or NK-LGL lymphocytosis or chronic NK-LGL\n             leukemia:\n\n               -  Specific criteria for T-LGL leukemia:\n\n          -  Expression of LGL surface markers compatible with an activated T-cell (commonly\n             alpha-beta+/CD3+/CD8+/CD57+ and/or CD16+) phenotype or gamma-delta+ T cells;\n\n          -  Clonal rearrangement of TCR\u03b3 gene using PCR or specific and clonal V\u03b2 expression\n             using FCM.\n\n               -  Specific criteria for NK-LGL lymphocytosis or chronic NK LGL leukemia:\n\n          -  Expression of LGL surface markers compatible with a NK cell (commonly CD3-/CD8+/CD16+\n             and/or CD16+/CD56+) phenotype;\n\n          -  CD56+ or CD16+ NK cells greater than 0.75x109/L;\n\n          -  The term of chronic NK-LGL lymphocytosis is used for patients with chronic illness\n             (NB: patients with massive tissue LGL infiltration of the spleen, liver and bone\n             marrow and presenting aggressive clinical behavior are considered as having\n             aggressive NK-LGL leukemia and should not be included).\n\n          -  Age above 18 years\n\n          -  ECOG performance status of 0-2\n\n          -  Life expectancy of at least 1 year\n\n          -  Lack of previous treatment (except with G-CSF or transfusions)\n\n          -  At least one indication of treatment:\n\n               -  Isolated severe neutropenia (ANC <0.5x109/L) or neutropenia (ANC <1.5x109/L)\n                  with two or more infections requiring antibiotics;\n\n               -  Anemia (whatever the underlying mechanism: pure red cell   aplasia or marrow\n                  infiltration) requiring transfusions greater than 2 units for two months prior\n                  to inclusion, or symptomatic anemia (hemoglobin <10g/dl) with impairment of the\n                  quality of life;\n\n               -  Associated complications such as systemic diseases or auto-immune diseases (i.e.\n                  recurrent uveitis, cutaneous vasculitis, autoimmune hemolytic anemia, idiopathic\n                  thrombocytopenic purpura, rheumatoid arthritis resistant to steroids and/or\n                  immunomodulator agents (colchicin, disulone, hydrochloroquine)) and justifying a\n                  treatment with methotrexate or cyclophosphamide\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Inability to understand or to follow study procedures\n\n          -  Prior or concurrent malignancy within the past 5 years except inactive\n             nonmelanomatous skin cancer or carcinoma in situ of the cervix\n\n          -  Other serious medical illnesses, such as hepatic, renal, cardiac, pulmonary,\n             neurologic, or metabolic disease that would preclude the patient's ability to\n             tolerate methotrexate, cyclophosphamide, or ciclosporine A\n\n          -  Reactive LGL lymphocytosis (i.e. after viral infection)\n\n          -  ALAT/ASAT or alkalin phosphatases >3 times normal values\n\n          -  Creatinine clairance <50 ml/min\n\n          -  Serologic evidence of HIV, hepatitis C or hepatitis B infection\n\n          -  Non effective contraception\n\n          -  Positive pregnancy test\n\n          -  Nursing woman"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976182", 
            "org_study_id": "LGL"
        }, 
        "intervention": [
            {
                "arm_group_label": "METHOTREXATE", 
                "description": "methotrexate 10mg / m\u00b2 orally once a week, (at split doses of 5 mg/m2 in the morning and 5 mg/m2 at night), that is to say 2 tablets of 2.5 mg at each take, during 4 months.", 
                "intervention_name": "Methotrexate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "CYCLOPHOSPHAMIDE", 
                "description": "cyclophosphamide 100 mg orally once daily, that is to say 2 tablets of 50 mg at each take, during 4 months.", 
                "intervention_name": "Cyclophosphamide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Immunosuppressive Agents", 
                "Methotrexate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "large granular lymphocytes leukemia", 
            "immunosuppressive drugs", 
            "methotrexate", 
            "cyclophosphamide", 
            "efficiency", 
            "phase II randomized controlled trial"
        ], 
        "lastchanged_date": "November 4, 2013", 
        "location": [
            {
                "contact": {
                    "email": "royer.bruno@chu-amiens.fr", 
                    "last_name": "Bruno ROYER, MD", 
                    "phone": "03 22 45 59 14", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "CHU Sud"
                }, 
                "investigator": {
                    "last_name": "Bruno Royer, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "MaTruchan@chu-angers.fr", 
                    "last_name": "Malgorzata truchand-Graczyk, MD", 
                    "phone": "02 41 35 45 24", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49033"
                    }, 
                    "name": "CHU Angers"
                }, 
                "investigator": {
                    "last_name": "Malgorazata Truchand-Graczyk, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daniel.re@ch-antibes.fr", 
                    "last_name": "Daniel RE, MD", 
                    "phone": "04 97 24 77 46", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Antibes", 
                        "country": "France"
                    }, 
                    "name": "Intern medecine Service - CH Antibes-Juan-les-Pins"
                }, 
                "investigator": {
                    "last_name": "Daniel RE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hzerazhi@ch-avignon.fr", 
                    "last_name": "Hac\u00e8ne ZERAZHI, MD", 
                    "phone": "04 32 75 93 93", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Avignon", 
                        "country": "France", 
                        "zip": "84902"
                    }, 
                    "name": "Hematology Service - CH Avignon"
                }, 
                "investigator": {
                    "last_name": "Zerazhi Hac\u00e8ne, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "abanos@ch-cotebasque.fr", 
                    "last_name": "Anne Banos, MD", 
                    "phone": "05 59 44 38 32", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Bayonne", 
                        "country": "France"
                    }, 
                    "name": "Hematology Service - CH de la cote basque"
                }, 
                "investigator": {
                    "last_name": "Anne Banos, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kamel.ghomari@ch-beauvais.fr", 
                    "last_name": "Mustapha Ghomari, MD", 
                    "phone": "03 44 11 23 90", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Beauvais", 
                        "country": "France", 
                        "zip": "60021"
                    }, 
                    "name": "hematology service - CH Beauvais"
                }, 
                "investigator": {
                    "last_name": "Mustapha Ghomari, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "abrion@chu-besancon.fr", 
                    "last_name": "Annie BRION, MD", 
                    "phone": "03 81 66 82 32", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Besan\u00e7on", 
                        "country": "France", 
                        "zip": "25030"
                    }, 
                    "name": "Hematology Service - CH Jean Minjoz"
                }, 
                "investigator": {
                    "last_name": "Annie BRION, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "alain.saad@ch-beziers.fr", 
                    "last_name": "Alain SAAD, MD", 
                    "phone": "04 67 35 70 63", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Beziers", 
                        "country": "France", 
                        "zip": "34500"
                    }, 
                    "name": "Hematology Service - CH Beziers"
                }, 
                "investigator": {
                    "last_name": "Alain SAAD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "florence.cymbalista@avc.aphp.fr", 
                    "last_name": "Florence Cymbalista, MD", 
                    "phone": "01 48 95 56 40", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Bobigny", 
                        "country": "France", 
                        "zip": "93009"
                    }, 
                    "name": "Hematology Unit - HOpital Avicienne"
                }, 
                "investigator": {
                    "last_name": "Florence Cymbalista, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "b.choufi@ch-boulogne.fr", 
                    "last_name": "bachra CHOUFI, MD", 
                    "phone": "03 21 99 82 02", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Boulogne sur Mer", 
                        "country": "France", 
                        "zip": "62321"
                    }, 
                    "name": "Hematology Service - CH Docteur Duchenne"
                }, 
                "investigator": {
                    "last_name": "Bachra CHOUFI, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hussam.saad@chu-brest.fr", 
                    "last_name": "Hussam SAAD, MD", 
                    "phone": "02 98 22 34 21", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }, 
                    "name": "Hematology Service - CH de Brest"
                }, 
                "investigator": {
                    "last_name": "hussam SAAD, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jp.vilque@baclesse.fr", 
                    "last_name": "Jean-Pierre VILQUE, MD", 
                    "phone": "02 31 45 50 12", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Caen", 
                        "country": "France", 
                        "zip": "14076"
                    }, 
                    "name": "Hematology Service - CH Fran\u00e7ois Baclesse"
                }, 
                "investigator": [
                    {
                        "last_name": "Jean-Pierre VILQUE, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Boris BIENVENU, MD", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mmaigre@ch-chartres.fr", 
                    "last_name": "michel maigre, MD", 
                    "phone": "02 37 30 30 77", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Chartres", 
                        "country": "France", 
                        "zip": "28018"
                    }, 
                    "name": "hematology Service - CH Louis Pasteur"
                }, 
                "investigator": {
                    "last_name": "Michel Maigre, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "otournilhac@chu-clermontferrand.fr", 
                    "last_name": "Olivier Tournilhac, MD", 
                    "phone": "04 73 75 00 65", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Clermont-Ferrand", 
                        "country": "France", 
                        "zip": "63003"
                    }, 
                    "name": "hematology Service - CHU Estaing"
                }, 
                "investigator": [
                    {
                        "last_name": "Joel Fleury, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Olivier Tournilhac, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mohammed.belkaid@ch-colmar.fr", 
                    "last_name": "Mohammed Belkaid, MD", 
                    "phone": "03 89 12 43 29", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Colmar", 
                        "country": "France", 
                        "zip": "68024"
                    }, 
                    "name": "Hematology Service - Civils hospital"
                }, 
                "investigator": {
                    "last_name": "Mohammed BELKAID, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "celia.salanoubat@ch-sud-francilien.fr", 
                    "last_name": "C\u00e9lia SALANOUBAT, MD", 
                    "phone": "01 60 90 31 78", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Corbeil Essonnes", 
                        "country": "France", 
                        "zip": "91110"
                    }, 
                    "name": "Hematology Service CHSF"
                }, 
                "investigator": {
                    "last_name": "C\u00e9lia SALANOUBAT, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jehan.dupuis@hmn.aphp.fr", 
                    "last_name": "Jehan DUPUIS, MD", 
                    "phone": "01 49 81 41 74", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Creteil", 
                        "country": "France", 
                        "zip": "94000"
                    }, 
                    "name": "CHU Henri Mondor Lymphoid Hemopathy Unit"
                }, 
                "investigator": [
                    {
                        "last_name": "Jehan DUPUIS, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Marc MICHEL, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "emmanuelle.ferrant@chu-dijon.fr", 
                    "last_name": "Emmanuelle FERRANT, MD", 
                    "phone": "03 80 29 50 41", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "CHU Dijon Hematology Unit"
                }, 
                "investigator": {
                    "last_name": "Emmanuelle FERRNAT, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lmolina@chu-grenoble.fr", 
                    "last_name": "Lysiane MOLINA, MD", 
                    "phone": "04 76 76 76 69", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "Hematology Unit CH Michalon"
                }, 
                "investigator": {
                    "last_name": "Lysiane Molina, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mourad.tiab@chd.vendee.fr", 
                    "last_name": "Mourad TIAB, MD", 
                    "phone": "02 51 44 61 73", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "La Roche sur Yon", 
                        "country": "France", 
                        "zip": "85925"
                    }, 
                    "name": "Hematology Unit CHD Vend\u00e9e"
                }, 
                "investigator": {
                    "last_name": "Mourad TIAB, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "klaribi@ch-lemans.fr", 
                    "last_name": "Kamel Laribi, MD", 
                    "phone": "02 43 43 29 59", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Mans", 
                        "country": "France", 
                        "zip": "72000"
                    }, 
                    "name": "Hematology Unit CH LE MANS"
                }, 
                "investigator": {
                    "last_name": "Kamel Laribi, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "b-cazin@chru-lille.fr", 
                    "last_name": "Bruno CAZIN, MD", 
                    "phone": "03 20 44 42 90", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Lille", 
                        "country": "France", 
                        "zip": "59037"
                    }, 
                    "name": "Hematology Unit CHRU Lille"
                }, 
                "investigator": {
                    "last_name": "Bruno Cazin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "bordessoule.urch@chu-limoges.fr", 
                    "last_name": "Dominique Bordessoule, MD", 
                    "phone": "05 55 05 66 42", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042"
                    }, 
                    "name": "Hematology Unit CHU Dupuytren"
                }, 
                "investigator": {
                    "last_name": "Dominique Bordessoule, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "aurrant@marseille.fnclcc.fr", 
                    "last_name": "Th\u00e9r\u00e8se Aurran-Schleinitz, MD", 
                    "phone": "04 91 22 38 66", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13009"
                    }, 
                    "name": "Hematology Unit - Institut Paoli-Calmettes"
                }, 
                "investigator": [
                    {
                        "last_name": "Th\u00e9r\u00e8se Aurran-Schleinitz, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "J\u00e9rome REY, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "regis.costello@free.fr", 
                    "last_name": "Regis Costello, MD", 
                    "phone": "04 91 38 41 50", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13005"
                    }, 
                    "name": "Hematology Unit CHU La Conception"
                }, 
                "investigator": {
                    "last_name": "Regis Costello, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "w-abarah@ch-meaux.fr", 
                    "last_name": "Wajed Abarah, MD", 
                    "phone": "01 64 35 38 75", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Meaux", 
                        "country": "France", 
                        "zip": "77100"
                    }, 
                    "name": "Hematology Unit CH Meaux"
                }, 
                "investigator": {
                    "last_name": "Wajed Abarah, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "i.guibaud@chr-metz-thionville.fr", 
                    "last_name": "Isabelle Guibaud, MD", 
                    "phone": "03 87 55 32 32", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Metz", 
                        "country": "France", 
                        "zip": "57000"
                    }, 
                    "name": "Hematology Unit CH Notre Dame Bon Secours"
                }, 
                "investigator": {
                    "last_name": "Isabelle Guibaud, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "g-cartron@chu-montpellier.fr", 
                    "last_name": "Guillaume CARTRON, MD", 
                    "phone": "04 67 33 83 62", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Montpellier", 
                        "country": "France", 
                        "zip": "34295"
                    }, 
                    "name": "Hematogy Unit CHU ST ELOI"
                }, 
                "investigator": {
                    "last_name": "Guillaume CARTRON, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "drenoub@ch-mulhouse.fr", 
                    "last_name": "Bernard DRENOU, MD", 
                    "phone": "03 89 64 77 85", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Mulhouse", 
                        "country": "France", 
                        "zip": "68070"
                    }, 
                    "name": "Hematology Unit CH E.MULLER"
                }, 
                "investigator": {
                    "last_name": "Bernard DRENOU, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "beatrice.mahe@chu-nantes.fr", 
                    "last_name": "Beatrice MAHE, MD", 
                    "phone": "02 40 08 32 54", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France"
                    }, 
                    "name": "Hematology Unit - CHU Hotel Dieu"
                }, 
                "investigator": {
                    "last_name": "Beatrice MAHE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "daniel.re@ch-antibes.fr", 
                    "last_name": "Daniel RE, MD", 
                    "phone": "04 92 03 16 18", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Nice", 
                        "country": "France"
                    }, 
                    "name": "Oncology Unit CH Antoine Lacassagne"
                }, 
                "investigator": {
                    "last_name": "Daniel RE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eric.jourdan@chu-nimes.fr", 
                    "last_name": "Eric JOURDAN, MD", 
                    "phone": "04 66 68 32 31", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Nimes", 
                        "country": "France", 
                        "zip": "30029"
                    }, 
                    "name": "hematology Unit CHU Caremeau"
                }, 
                "investigator": {
                    "last_name": "Eric Jourdan, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "magda.alexis@chr-orleans.fr", 
                    "last_name": "Magda ALEXIS, MD", 
                    "phone": "02 38 22 95 47", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Orleans", 
                        "country": "France", 
                        "zip": "45067"
                    }, 
                    "name": "Hematology Unit - CHR Orleans"
                }, 
                "investigator": {
                    "last_name": "Magda ALEXIS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "veronique.leblond@psl.aphp.fr", 
                    "last_name": "V\u00e9ronique LEBLOND, MD", 
                    "phone": "01 42 16 28 24", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75013"
                    }, 
                    "name": "Hematology Service - Hopital La Piti\u00e9 Salpetri\u00e8re"
                }, 
                "investigator": [
                    {
                        "last_name": "V\u00e9ronique LEBLOND, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Sylvain CHOQUET, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jean-marc.zini@sls.aphp.fr", 
                    "last_name": "Jean-Marc ZINI, MD", 
                    "phone": "01 42 49 92 97", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Hematology Unit - Hopital Saint Louis"
                }, 
                "investigator": {
                    "last_name": "Jean-Marc ZINI, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anne-vekhoff@sat.aphp.fr", 
                    "last_name": "Anne VEKHOFF, MD", 
                    "phone": "01 49 28 34 29", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }, 
                    "name": "Hematology Unit - Hopital Saint Antoine"
                }, 
                "investigator": {
                    "last_name": "Anne VEKHOFF, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "francois.dreyfus@cch.aphp.fr", 
                    "last_name": "Fran\u00e7ois DREYFUS, MD", 
                    "phone": "01 42 34 87 65", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75181"
                    }, 
                    "name": "Hematology Unit - Hopital Hotel Dieu"
                }, 
                "investigator": {
                    "last_name": "Fran\u00e7ois DREYFUS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "laurence.sanhes@ch-perpignan.fr", 
                    "last_name": "Laurence SANHES, MD", 
                    "phone": "04 68 61 64 48", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Perpignan", 
                        "country": "France", 
                        "zip": "66000"
                    }, 
                    "name": "Hematology Unit Hopital Saint Jean"
                }, 
                "investigator": {
                    "last_name": "Laurence SANHES, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "marie-sarah.dilhuydy@chu-bordeaux.fr", 
                    "last_name": "Marie-Sarah Dilhuydy, MD", 
                    "phone": "05 57 65 65 11", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Pessac", 
                        "country": "France", 
                        "zip": "33604"
                    }, 
                    "name": "Hematology Service- CH Haut Leveque"
                }, 
                "investigator": [
                    {
                        "last_name": "Marie-Sarah DILHUYDY, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Jean-Fran\u00e7ois VIALLARD, PUPH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "anne-sophie.michallet@chu-lyon.fr", 
                    "last_name": "Anne-Sophie Michallet, MD", 
                    "phone": "04 78 86 43 05", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Pierre Benite", 
                        "country": "France", 
                        "zip": "69310"
                    }, 
                    "name": "Hematology Unit CH LYON SUD"
                }, 
                "investigator": {
                    "last_name": "Anne-Sophie Michallet, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "c.tomowiac@chu-poitiers.fr", 
                    "last_name": "C\u00e9cile TOMOWIAC, MD", 
                    "phone": "05 49 44 43 07", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86000"
                    }, 
                    "name": "Hematology Unit CHU La Miletrie"
                }, 
                "investigator": {
                    "last_name": "C\u00e9cile TOMOWIAC, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "hugo.gonzalez@ch-pontoise.fr", 
                    "last_name": "Hugo GONZALEZ, MD", 
                    "phone": "01 30 75 47 35", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Pontoise", 
                        "country": "France", 
                        "zip": "95000"
                    }, 
                    "name": "Hematology Unit CH Ren\u00e9 DUBOS"
                }, 
                "investigator": {
                    "last_name": "Hugo GONZALEZ, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "forsinipiocelle@ch-annecy.fr", 
                    "last_name": "Fr\u00e9d\u00e9rique orsini-piocelle, MD", 
                    "phone": "04 50 63 66 08", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Pringy", 
                        "country": "France", 
                        "zip": "74374"
                    }, 
                    "name": "CH Annecy - Hematology Service"
                }, 
                "investigator": {
                    "last_name": "Fr\u00e9d\u00e9rique Orsini-Piocelle, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "adelmer@chu-reims.fr", 
                    "last_name": "Alain DELMER, MD", 
                    "phone": "03 26 78 36 44", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51092"
                    }, 
                    "name": "Hematology Unit- Hopital Robert Debr\u00e9"
                }, 
                "investigator": {
                    "last_name": "Alain DELMER, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "thierry.lamy@chu-rennes.fr", 
                    "last_name": "Thierry Lamy, PUPH", 
                    "phone": "02 99 28 42 91", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Rennes", 
                        "country": "France", 
                        "zip": "35000"
                    }, 
                    "name": "Hematology Service - CHU of Rennes"
                }, 
                "investigator": {
                    "last_name": "Thierry Lamy, PUPH", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "stelep@rouen.fnclcc.fr", 
                    "last_name": "St\u00e9phane LEPETRE, MD", 
                    "phone": "02 32 08 22 23", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76038"
                    }, 
                    "name": "Hematology Unit - CH Becquerel"
                }, 
                "investigator": {
                    "last_name": "St\u00e9phane LEPETRE, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "karine.augeul-meunier@icloire.fr", 
                    "last_name": "Karine AUGEUL-MEUNIER, MD", 
                    "phone": "04 77 91 70 60", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Priest en Jarez", 
                        "country": "France", 
                        "zip": "60008"
                    }, 
                    "name": "Oncology Unit - Institut de canc\u00e9rologie de la Loire"
                }, 
                "investigator": {
                    "last_name": "Karine AUGEUL-MEUNIER, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "r.garidi@ch-stquentin.fr", 
                    "last_name": "Reda GARIDI, MD", 
                    "phone": "03 23 06 78 61", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Saint Quentin", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "CH Saint Quentin Oncohematology"
                }, 
                "investigator": {
                    "last_name": "Reda GARIDI, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ysebaert.l@chu-toulouse.fr", 
                    "last_name": "Loic YSEBAERT, MD", 
                    "phone": "05 61 77 76 68", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "zip": "31000"
                    }, 
                    "name": "Hematology Unit CHU Toulouse"
                }, 
                "investigator": [
                    {
                        "last_name": "Loic YSEBEART, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Daniel ADOUE, PUPH", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "c.dartigeas@chu-tours.fr", 
                    "last_name": "Caroline DARTIGAS, MD", 
                    "phone": "02 47 47 37 12", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Hematology Unit CHU Bretonneau"
                }, 
                "investigator": {
                    "last_name": "Caroline DARTIGAS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "p.feugier@chu-nancy.fr", 
                    "last_name": "Pierre FEUGIER, MD", 
                    "phone": "03 83 15 32 82", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Vandoeuvre les Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Hematology Unit Hopitaux de Brabois"
                }, 
                "investigator": {
                    "last_name": "Pierre FEUGIER, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "henry.jardel@ch-bretagne-atlantique.fr", 
                    "last_name": "Henry JARDEL, MD", 
                    "phone": "02 97 01 41 45", 
                    "phone_ext": "+33"
                }, 
                "facility": {
                    "address": {
                        "city": "Vannes", 
                        "country": "France", 
                        "zip": "56017"
                    }, 
                    "name": "Intern Medecine Unit CHBA"
                }, 
                "investigator": {
                    "last_name": "Henry JARDEL, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective, Sequential Multiple Assignment, Multicentric, Phase II Randomized Controlled Trial on Two Parallel Groups Comparing the Efficacy of Two Immunosuppressive Drugs (Methotrexate, Cyclophosphamide) in Large Granular Lymphocytes Leukemia", 
        "overall_contact": {
            "email": "thierry.lamy@chu-rennes.fr", 
            "last_name": "Thierry Lamy, PUPH", 
            "phone": "02 99 28 42 91", 
            "phone_ext": "+33"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "France: Committee for the Protection of Personnes", 
                "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The main endpoint will be the hematological CR rate evaluated after 4 months of treatment (binary endpoint). Complete response (CR) is defined as a normalization of clinical examination (disappearance of splenomegaly) and a complete normalization of blood counts (i.e., hemoglobin >12g/dL, platelets >150x109/L, ANC >1.5x109/L), lymphocytosis <4x109/L and circulating LGL in the normal range (<0.3x109/L). The number of LGL will be quantitated on blood smears.", 
            "measure": "Complete response (CR)", 
            "safety_issue": "No", 
            "time_frame": "at Month 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976182"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Hematological overall response rate (ORR) defined as the sum of complete responses and partial responses over the total number of patients.", 
                "measure": "overall response rate (ORR)", 
                "safety_issue": "No", 
                "time_frame": "at Month 4, and at Month 8 and Month 12 in non-responders at Month 4"
            }, 
            {
                "description": "Complete response (CR) is defined as a normalization of clinical examination (disappearance of splenomegaly) and a complete normalization of blood counts (i.e., hemoglobin >12g/dL, platelets >150x109/L, ANC >1.5x109/L), lymphocytosis <4x109/L and circulating LGL in the normal range (<0.3x109/L). The number of LGL will be quantitated on blood smears.", 
                "measure": "Complete response (CR)", 
                "safety_issue": "No", 
                "time_frame": "at Month 8 and Month 12"
            }, 
            {
                "description": "Hematological partial response (PR) defined as an improvement in blood counts which do not meet criteria for complete remission (e.g., ANC increasing more than 50% and reaching more than 0.5 but less than 1.5x109/L with non-recurrence of infections, or hemoglobin level increasing more than 2 g/dL from baseline and transfusion requirements stopping without normalization of the hemoglobin level defined as hemoglobin >12g/dL).", 
                "measure": "Hematological partial response (PR)", 
                "safety_issue": "No", 
                "time_frame": "at Month 4, Month 8 and Month 12"
            }, 
            {
                "description": "Progressive disease defined as worsening of cytopenia or organomegaly or incidence of infections.", 
                "measure": "Progressive disease", 
                "safety_issue": "No", 
                "time_frame": "at Month 4, Month 8 and Month 12"
            }, 
            {
                "description": "Time-to-relapse (censored variable). Relapse is defined as re-occurrence of either neutropenia or anemia (ANC <1x109/L and/or hemoglobin <10g/dL) or clonal LGL >0.5x109/L in complete responders, or as a return to baseline values of either ANC or hemoglobin in partial responders, at two monthly consecutive blood tests.", 
                "measure": "Time-to-relapse", 
                "safety_issue": "No", 
                "time_frame": "from Month 4 to endpoint (in first-line treatment responders)"
            }, 
            {
                "description": "Time-to-relapse (censored variable).  Relapse is defined as re-occurrence of either neutropenia or anemia (ANC <1x109/L and/or hemoglobin <10g/dL) or clonal LGL >0.5x109/L in complete responders, or as a return to baseline values of either ANC or hemoglobin in partial responders, at two monthly consecutive blood tests.", 
                "measure": "Time-to-relapse", 
                "safety_issue": "No", 
                "time_frame": "from Month 8 to endpoint (in second-line treatment responders)"
            }, 
            {
                "description": "Molecular remission defined as the disappearance of the clonal pattern of TCR gamma multiplex rearrangement and Phenotypic remission is defined as :\nFor the T subtype: disappearance of the excess of CD3+/CD8+ cells (or disappearance of the LGL clone according to the specific subtype observed at inclusion);\nFor the NK subtype: disappearance of the excess of CD3-/CD56+ cells (or disappearance of the LGL clone according to the specific subtype observed at inclusion)", 
                "measure": "Molecular remission", 
                "safety_issue": "No", 
                "time_frame": "at Month 4 and Month 12 for hematological complete responders"
            }, 
            {
                "description": "Adverse events rate", 
                "measure": "Adverse events rate", 
                "safety_issue": "Yes", 
                "time_frame": "Month 2, Month 4, Month 6, Month 8, Month 10, Month 12"
            }, 
            {
                "description": "Compliance", 
                "measure": "Compliance", 
                "safety_issue": "No", 
                "time_frame": "Month 2, Month 4, Month 6, Month 8, Month 10, Month 12"
            }, 
            {
                "description": "Identification of a relationship between the response to treatment and the phenotypic subtype characterized by the panel of monoclonal antibodies defined in the ancillary study subsection.", 
                "measure": "relationship between the response to treatment and the phenotypic subtype", 
                "safety_issue": "No", 
                "time_frame": "Day 1"
            }
        ], 
        "source": "Rennes University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rennes University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}